CTKB: Cytek Biosciences, Inc. Common Stock Company Profile & Statistics

About

Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.

Info & Links

CEO

Wenbin Jiang

Headquarters

47215 Lakeview Blvd.
Fremont, CA 94538, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

676

Cytek Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

670.46M

Enterprise Value

509.39M

Enterprise Value/EBITDA(ttm)

-37.81

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.43

Price to Book(mrq)

1.83

Price to Cash(ytd)

212.50

Profitability

Gross Margin(ttm)

54.73%

Operating Margin(ttm)

-5.01%

Profit Margin(ttm)

-6.21%

Return on Equity(ttm)

-2.58%

Return on Invested Capital(ttm)

-2.60%

Return on Assets(ttm)

-2.05%

Income Statement

Revenue(ttm)

201.21M

Revenue Per Share(ttm)

1.56

Gross Profit(ttm)

110.50M

EBITDA(ttm)³

-13.47M

Net Income Available to Common(ttm)

-10.16M

Diluted EPS(ttm)

-0.08

Share Statistics

Beta (5Y Monthly)

1.40

52-Week Change

-38.96%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

128.81M

Dividend Yield

0.00%

Float⁴

116.44M

% Held by Insiders

9.60%

% Held by Institutions

69.46%

Balance Sheet

Total Cash(mrq)

277.81M

Total Cash Per Share(mrq)

2.16

Total Debt(mrq)

1.24M

Total Debt/Equity(mrq)

0.32%

Current Ratio(mrq)

6.21%

Quick Ratio(mrq)

5.47%

Book Value Per Share(mrq)

2.97

Cash Flow

Operating Cash Flow Per Share(ytd)

0.18

Free Cash Flow(ytd)

20.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CTKB

Cytek Biosciences, Inc. Common Stock

Cytek Biosciences, Inc. Common Stock Profile